Investment firm Maxim Group recently announced an adjustment to the target share price of biopharmaceutical company Plus Therapeutics, Inc., lowering it from $37.5 to $12.

老虎证券2026/04/07 04:24

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This adjustment mainly reflects the company’s recent implementation of a 1-for-25 reverse stock split. After the reverse split, the total number of shares outstanding decreases accordingly, and the price per share rises proportionally. As a result, the target price needs to be technically revised to maintain consistency in the valuation benchmark.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Investment firm Maxim Group recently announced an adjustment to the target share price of biopharmaceutical company Plus Therapeutics, Inc., lowering it from $37.5 to $12.

You may also like

Crypto prices